 |
|
Development and prognosis of hepatocellular carcinoma in patients with diabetes
Takuma Nakatsuka, Ryosuke Tateishi
Clin Mol Hepatol. 2023;29(1):51-64. Published online 2022 Jul 29 DOI: https://doi.org/10.3350/cmh.2022.0095
|
|
Citations to this article as recorded by
 Triterpenes from Ganoderma lucidum inhibit hepatocellular carcinoma by regulating enhancer-associated lncRNA in vivo
Ruolin Zhao, Caiyun Zhang, Chenchen Tang, Xinxin Wu, Sheng Hu, Qingqiong Luo, Ning Jia, Lingzhi Fan, Yixing Wang, Wencheng Jiang, Qilong Chen
Journal of Ethnopharmacology.2025; 336: 118706. CrossRef Ashwagandharishta compounds possess affinity interactions against diabetes-linked liver cancer: Implications from network pharmacology, molecular docking and dynamics simulations
Annadurai Vinothkanna, Ligang Chen, Ragothaman Prathiviraj, Srinivasan Prabhu, Rekha Thiruvengadam, Thasma Raman Sivakumar
South African Journal of Botany.2025; 177: 26. CrossRef The interplay between chronic hepatitis B and diabetes mellitus: A narrative and concise review
Shang‐Chin Huang, Jia‐Horng Kao
The Kaohsiung Journal of Medical Sciences.2024; 40(1): 6. CrossRef Exploring the links between types 2 diabetes and liver‐related complications: A comprehensive review
Lukas Otero Sanchez, Yuping Chen, Guillaume Lassailly, Xiaolong Qi
United European Gastroenterology Journal.2024; 12(2): 240. CrossRef The Role of Type 2 Diabetes Mellitus–Related Risk Factors and Drugs in Hepatocellular Carcinoma
Yuhua Mai, Liheng Meng, Ganlu Deng, Yingfen Qin
Journal of Hepatocellular Carcinoma.2024; Volume 11: 159. CrossRef Hepatic Stellate Cell‐Targeting Micelle Nanomedicine for Early Diagnosis and Treatment of Liver Fibrosis
Lei Wang, Jieying Zhou, Jian Wang, Xiaotang Wang, Haijuan Dong, Lingzhi Zhao, Junchen Wu, Juanjuan Peng
Advanced Healthcare Materials.2024;[Epub] CrossRef Liver and cardiovascular disease outcomes in metabolic syndrome and diabetic populations: Bi-directional opportunities to multiply preventive strategies
Alhussain Yasin, Madison Nguyen, Angad Sidhu, Priyanka Majety, Jared Spitz, Amon Asgharpour, Mohammad S. Siddiqui, Laurence S. Sperling, Arshed A. Quyyumi, Anurag Mehta
Diabetes Research and Clinical Practice.2024; 211: 111650. CrossRef SGLT2i impact on HCC incidence in patients with fatty liver disease and diabetes: a nation-wide cohort study in South Korea
Hyo Jung Cho, Eunyoung Lee, Soon Sun Kim, Jae Youn Cheong
Scientific Reports.2024;[Epub] CrossRef MLKL promotes hepatocarcinogenesis through inhibition of AMPK-mediated autophagy
Xianjun Yu, Mengyuan Feng, Jian Guo, Haoyu Wang, Jun Yu, Anjie Zhang, Jingyi Wu, Yamei Han, Zequn Sun, Yingying Liao, Qun Zhao
Cell Death & Differentiation.2024; 31(8): 1085. CrossRef Associations between “Cancer Risk”, “Inflammation” and “Metabolic Syndrome”: A Scoping Review
Elsa Vitale, Alessandro Rizzo, Kazuki Santa, Emilio Jirillo
Biology.2024; 13(5): 352. CrossRef The Association of Metformin, Other Antidiabetic Medications, and Statins with the Prognosis of Hepatocellular Carcinoma in Patients with Type 2 Diabetes: A Retrospective Cohort Study
Iida Tuunanen, Ari Hautakoski, Heikki Huhtamäki, Martti Arffman, Reijo Sund, Ulla Puistola, Peeter Karihtala, Arja Jukkola, Elina Urpilainen
Biomedicines.2024; 12(8): 1654. CrossRef Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication
Chung-Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, Ming-Lung Yu
Clinical and Molecular Hepatology.2024; 30(3): 326. CrossRef Glycemic Burden and Clinical Outcomes of Early Stage Hepatocellular Carcinoma after Curative Treatment
Hyun Joo Lee, Moon Seok Choi, Byeong Geun Song, Won Seok Kang, Geum Youn Gwak, Myung Ji Goh, Yong Han Paik, Joon Hyeok Lee, Dong Hyun Sinn
Cancers.2024; 16(15): 2652. CrossRef A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B
Moon Haeng Hur, Terry Cheuk-Fung Yip, Seung Up Kim, Hyun Woong Lee, Han Ah Lee, Hyung-Chul Lee, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Jun Yong Park, Sang Hoon Ahn, Beom Kyung Kim, Hwi Young Kim, Yeon Seok Seo, Hyunjae Shin, Jeayeon Park, Yunmi Ko, Yo
Journal of Hepatology.2024;[Epub] CrossRef Reply to correspondence on “Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: a network meta-analysis”
Tian-Yi Ren, Mohammed Eslam, Jian-Gao Fan
Clinical and Molecular Hepatology.2024; 30(4): 1039. CrossRef A predicted epithelial-to-mesenchymal transition-associated mRNA/miRNA axis contributes to the progression of diabetic liver disease
Alina-Veronica Ghionescu, Andrei Sorop, Ekaterini Linioudaki, Cristin Coman, Lorand Savu, Marton Fogarasi, Daniela Lixandru, Simona Olimpia Dima
Scientific Reports.2024;[Epub] CrossRef Diabetes Mellitus Negatively Impacts Outcomes of HBV-Related Hepatocellular Carcinoma Following Thermal Ablation
Kuo-Cheng Wu, I-Cheng Lee, Chien-An Liu, Nai-Chi Chiu, Shao-Jung Hsu, Pei-Chang Lee, Chi-Jung Wu, Chen‐Ta Chi, Jiing-Chyuan Luo, Ming-Chih Hou, Yi-Hsiang Huang
Journal of Hepatocellular Carcinoma.2024; Volume 11: 2257. CrossRef Evolution of characteristics of MASLD with and without diabetes: a meta-analysis of placebo arms
Han Ah Lee, Hye Ah Lee, Hwi Young Kim
Scientific Reports.2024;[Epub] CrossRef The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea
Yuri Cho, Bo Hyun Kim, Joong-Won Park
Clinical and Molecular Hepatology.2023; 29(1): 99. CrossRef The association between alcohol consumption and the risk of hepatocellular carcinoma according to glycemic status in Korea: A nationwide population-based study
Eun Ju Cho, Goh Eun Chung, Jeong-Ju Yoo, Yuri Cho, Dong Wook Shin, Yoon Jun Kim, Jung-Hwan Yoon, Kyungdo Han, Su Jong Yu
PLOS Medicine.2023; 20(6): e1004244. CrossRef Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals
Takao Watanabe, Yoshio Tokumoto, Kouji Joko, Kojiro Michitaka, Norio Horiike, Yoshinori Tanaka, Atsushi Hiraoka, Fujimasa Tada, Hironori Ochi, Yoshiyasu Kisaka, Seiji Nakanishi, Sen Yagi, Kazuhiko Yamauchi, Makoto Higashino, Kana Hirooka, Makoto Morita, Y
Scientific Reports.2023;[Epub] CrossRef Serum resistin and the risk for hepatocellular carcinoma in diabetic patients
Mona Mohamed Ibrahim Abdalla
World Journal of Gastroenterology.2023; 29(27): 4271. CrossRef Exploring Opportunities to Enhance the Screening and Surveillance of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease (NAFLD) through Risk Stratification Algorithms Incorporating Ultrasound Elastography
Madalina-Gabriela Taru, Monica Lupsor-Platon
Cancers.2023; 15(16): 4097. CrossRef To do one and to get more: Part II. Diabetes and metabolic dysfunction-associated fatty liver diseases
Wen-Ling Lee, Peng-Hui Wang, Szu-Ting Yang, Chia-Hao Liu, Wen-Hsun Chang, Fa-Kung Lee
Journal of the Chinese Medical Association.2022; 85(12): 1109. CrossRef
|